Skip to main contentAI and Advanced
/
JHS · NSEBSE SENSEX74,294.96-0.03%BSE |
NIFTY 5023,346.4+0.33%NSE |
NIFTY BANK56,358.7+0.54%NSE |
NIFTY IT28,854.55-1.03%NSE |
NIFTY AUTO27,129-0.11%NSE |
NIFTY FMCG45,466.8-0.23%NSE |
NIFTY PHARMA26,710.1+0.49%NSE |
NIFTY 50022,840.55+0.82%NSE |
JH
NSE · Equity shares · Personal & Household Prods.0.08 · 0.94%
JHS Svendgaard Laboratories JHS
NSE:INR 8.59
BSE:INR 8.55
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for JHS
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 8.51
Day rangeINR 8.51 — INR 8.85
52-week rangeINR 6.15 — INR 13.9
Volume46,544
Market cap62.76
P/ENot available
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)101.69
Net Income (INR Cr)-1.92
Rev Growth (5 Year %)0.18
Book Value19.68
EPS-0.22
Price/BV0.44Computed
Research path: Interpret JHS Svendgaard Laboratories's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
JHSJHS Svendgaard Laboratories1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 215.22 | 201.17 | 197.05 |
| Cash Equivalents | 3.75 | 6.54 | 4.7 |
| Other Liabilities Total | 2.42 | 2.53 | 2.67 |
| Accrued Expenses | 0.19 | 1.8 | 1.61 |
| Common Stock Total | 87.41 | 85.6 | 78.4 |
| Other Current Assets Total | 10.79 | 1.23 | 5.31 |
| Total Assets | 215.22 | 201.17 | 197.05 |
| Current Portof LT Debt/Capital Leases | 9.33 | 0.95 | 0.65 |
| Total Equity | 174.67 | 172.73 | 169.88 |
| Long Term Investments | 6.52 | 5.9 | 3.74 |
| Retained Earnings(Accumulated Deficit) | 87.26 | -36.24 | -18.94 |
| Total Common Shares Outstanding | 8.74 | 8.56 | 7.84 |
| Tangible Book Valueper Share Common Eq | 19.68 | 19.79 | 21.23 |
| Goodwill Net | 0.8 | 0.8 | 0.8 |
| Total Liabilities | 40.55 | 28.44 | 27.17 |
| Total Debt | 14.85 | 6.46 | 5.13 |
| Short Term Investments | 16.75 | 11.77 | 0.35 |
| Cashand Short Term Investments | 20.51 | 18.31 | 5.05 |
| Total Receivables Net | 16.96 | 15.16 | 15.63 |
| Accounts Receivable-Trade Net | 16.76 | 13.52 | 13.85 |
| Property/Plant/Equipment Total-Net | 90.63 | 87.04 | 87.82 |
| Total Current Liabilities | 32.61 | 24.71 | 23.34 |
| Total Inventory | 15.17 | 18.97 | 17.48 |
| Accounts Payable | 17.86 | 13.44 | 14.1 |
| Other Currentliabilities Total | 5.23 | 4.21 | 3.67 |
| Total Long Term Debt | 5.52 | 1.21 | 1.17 |
| Intangibles Net | 1.86 | 2.49 | 2.62 |
| Other Long Term Assets Total | 50.26 | 5.76 | 12.41 |
| Note Receivable-Long Term | 1.73 | 45.36 | 46.01 |
| Total Current Assets | 63.42 | 53.83 | 43.66 |
| Capital Lease Obligations | 5.52 | 1.21 | 1.17 |
| Accumulated Depreciation Total | Not available | -41.26 | -42.02 |
| Other Equity Total | Not available | 0.22 | 0.08 |
| Prepaid Expenses | Not available | 0.15 | 0.19 |
| Additional Paid-In Capital | Not available | 123.15 | 110.35 |
| Property/Plant/Equipment Total-Gross | Not available | 128.31 | 129.02 |
| Notes Payable/Short Term Debt | Not available | 4.3 | 3.31 |
Fundamentals
Valuation and ratios
Growth
Debt 5Yr CAGR %16.2
Margins
Operating Margin 12m-4.8
Operating Margin 5y Avg-15.5
Net Profit Margin 12m-1.89
Net Profit Margin 5y-10.47
Yield
Dividend Yield %0
Valuation
Price to Sale Ratio0.62
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskHigh risk
Board Risk55.13
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Hindustan Unilever | INR 2,152.5 | 5.07 L | 48.32 | — |
| Godrej Consumer Products | INR 1,060.95 | 1.09 L | 54.2 | — |
| Marico | INR 857.8 | 1.11 L | 62.16 | — |
| Dabur India | INR 424.45 | 75,295.41 | 39.98 | — |
| Cupid | INR 204.95 | 27,558.82 | 271.87 | — |
Shareholding
Ownership
- Promoter
- 33.85%
- FII
- 3.14%
- Other
- 63.01%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
JHS Svendgaard EGM approves warrant issuance - scanx.tradeMarket news · 2 Jun 2026, 6:50 pm
JHS Svendgaard EGM approves warrant issuance scanx.trade
JHS Svendgaard reports consolidated net loss of ₹38.55 lakh in FY26 - scanx.tradeMarket news · 30 May 2026, 11:31 pm
JHS Svendgaard reports consolidated net loss of ₹38.55 lakh in FY26 scanx.trade
JHS Svendgaard Retail Ventures Ltd Holds EGM, Voting Results Pending - WhalesbookMarket news · 30 May 2026, 3:23 pm
JHS Svendgaard Retail Ventures Ltd Holds EGM, Voting Results Pending Whalesbook
JHS Svendgaard narrows net loss to ₹192.24 lakh in FY26 - scanx.tradeMarket news · 30 May 2026, 12:30 pm
JHS Svendgaard narrows net loss to ₹192.24 lakh in FY26 scanx.trade
JHS Svendgaard Consolidated March 2026 Net Sales at Rs 32.70 crore, up 29.88% Y-o-Y - Moneycontrol.comMarket news · 28 May 2026, 10:22 am
JHS Svendgaard Consolidated March 2026 Net Sales at Rs 32.70 crore, up 29.88% Y-o-Y Moneycontrol.com
JHS Svendgaard Q4 FY26: Steep Losses Overshadow Revenue Growth as Operational Challenges Mount - Markets MojoMarket news · 28 May 2026, 4:07 am
JHS Svendgaard Q4 FY26: Steep Losses Overshadow Revenue Growth as Operational Challenges Mount Markets Mojo
Corporate actions
Events
- annual General MeetingPOM
- board MeetingsAudited Results
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- annual General MeetingAGM
- board MeetingsEmployees Stock Option Plan
- board MeetingsQuarterly Results & ESOP
Rusaka Markets Community
Discussion and sentiment for JHS Svendgaard Laboratories
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
JHS Svendgaard Laboratories Limited is an India-based private label manufacturer of oral care products. The Company is engaged in manufacturing a range of oral and dental products for national and international brands. The Company is involved in the manufacturing and exporting of oral care and hygiene products, including toothbrushes, toothpastes, mouthwash, sanitizers and job work of detergent powder. Its domestic market products include toothbrushes, toothpaste, mouthwash, laundry sanitizer, and room fresheners. Its international market products include toothbrush, toothpaste and denture tablet. The Company’s subsidiary is JHS Svendgaard Mechanical and Warehouse Private Limited.
Company facts
- Industry
- Personal & Household Prods.
- Sector
- Personal & Household Prods.
- NSE Code
- JHS
- BSE Code
- 532771
Questions
Stock FAQ
What is the symbol and ISIN of JHS Svendgaard Laboratories?
JHS Svendgaard Laboratories has the symbol JHS and ISIN - INE544H01014.
What is the current price of JHS Svendgaard Laboratories?
JHS Svendgaard Laboratories is currently trading at INR 8.59.
What are the year high and year low of JHS Svendgaard Laboratories?
JHS Svendgaard Laboratories has a year high of INR 13.90 and a year low of INR 6.15.
What is the market capitalization of JHS Svendgaard Laboratories?
JHS Svendgaard Laboratories has a market capitalization of INR 62.76 crore.
What is the P/E ratio of JHS Svendgaard Laboratories?
JHS Svendgaard Laboratories has a P/E ratio of NA.
What is the dividend yield of JHS Svendgaard Laboratories?
JHS Svendgaard Laboratories has a dividend yield of 0.00%.
How is the financial performance of JHS Svendgaard Laboratories based on revenue, net income, and EPS?
JHS Svendgaard Laboratories has revenue of INR 101.69 crore, net income of INR -1.92 crore, and EPS of INR -0.23.
What is the book value of JHS Svendgaard Laboratories?
JHS Svendgaard Laboratories has a book value of INR 19.68.
What is the debt-to-equity ratio of JHS Svendgaard Laboratories?
JHS Svendgaard Laboratories has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of JHS Svendgaard Laboratories?
JHS Svendgaard Laboratories has a price-to-book ratio of 0.44 and a price-to-sales ratio of 0.62.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.